A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Clinical trial NCT04657224 · COMPLETED
Trial details
- NCT number
- NCT04657224
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-25
- Primary completion
- 2025-01-16
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.